laughter therapy for dementia

Laughter Therapy for Dementia: What the Science Says

Laughter therapy for dementia is an evidence-based, non-pharmacological intervention that reduces agitation, lifts mood, and supports cognitive wellbeing in patients with Alzheimer’s disease and related dementias – here’s what the clinical research reveals.

Table of Contents

Article Snapshot

Laughter therapy for dementia is a structured clinical intervention using humor – through comedy content, clown visits, or guided laughter exercises – to reduce agitation, lower depression scores, and improve quality of life in people living with Alzheimer’s disease and related cognitive conditions, with effects validated in peer-reviewed trials.

By the Numbers

  • Humor therapy produced an effect size of 0.4 for increasing happiness duration in nursing home residents at 13 weeks, compared with usual care (PubMed, 2014). [1]
  • A cluster randomized trial found humor therapy significantly reduced agitation in nursing home residents, with p = 0.045 for adjusted mean agitation score differences (BMJ Open, 2013). [2]
  • Geriatric Depression Scale scores improved from 7.00 to 5.63 following a four-week laughter therapy intervention in older adults (PMC, 2019). [3]
  • Benefits of humor therapy persisted at both 13-week and 26-week follow-up in a nursing home trial, indicating effects that outlast the immediate intervention period (BMJ Open, 2013). [2]

What Is Laughter Therapy for Dementia?

Laughter therapy for dementia is a structured, non-pharmacological intervention that uses humor – delivered through comedy media, professional clown visits, or facilitated laughter exercises – to reduce behavioral symptoms and improve emotional wellbeing in people with Alzheimer’s disease and related dementias. LaughMD, founded by Prof. Frank Chindamo, CHP – a former Saturday Night Live writer and Certified Humor Professional – brings together over 400 studies on the clinical benefits of laughter into practical guidance for patients, caregivers, and clinicians.

Dementia affects more than memory. Behavioral and psychological symptoms of dementia – including agitation, anxiety, depression, and social withdrawal – significantly reduce quality of life and are among the most challenging aspects of care for families and clinical teams. Pharmacological treatments for these symptoms carry serious risks, including sedation, increased fall risk, and cardiovascular side effects. Laughter therapy offers a complementary, side-effect-free alternative with a growing body of peer-reviewed evidence behind it.

Clinical humor interventions for dementia fall into two broad categories. The first uses spontaneous laughter, where humor content – comedy films, stand-up, or joke-telling – naturally triggers laughter responses. The second uses simulated laughter, where participants engage in intentional laughter exercises regardless of whether content is funny, relying on the physiological benefits of the laughter act itself. Both approaches have demonstrated measurable value in dementia care settings, though research shows their mechanisms and optimal use cases differ.

A 2010 review published in PMC concluded that laughter therapy is used in the treatment of dementia patients as a complementary and alternative intervention, noting its low cost, minimal training requirements, and absence of adverse effects as key practical advantages for care facilities and home environments alike (PMC, 2010). [4]

What Does the Clinical Evidence Show?

Clinical trials of laughter therapy in dementia and elderly care populations have produced consistent findings: humor-based interventions reduce agitation, lower depression, and increase observable happiness with effect sizes that are clinically meaningful. The most significant body of evidence comes from the Sydney Multisite Intervention of LaughterBosses and ElderClowns (SMILE) study, a cluster randomized trial conducted across nursing homes in Australia.

The SMILE study delivered humor therapy through trained LaughterBosses – staff members who incorporated humor into daily care – and professional ElderClowns who visited residents regularly. Compared with residents receiving usual care, those in the humor therapy group showed a statistically significant reduction in agitation scores, with a p-value of 0.045 for adjusted mean differences in raw agitation scores (BMJ Open, 2013). [2] That difference corresponded to roughly two agitated behaviors decreasing in frequency from daily to once a week – a change that caregivers and families experience as a substantial improvement in day-to-day quality of life (BMJ Open, 2013). [2]

As J. H. van der Wal et al. reported from the SMILE trial, “Humour therapy was successful in reducing agitation in the intervention at 13-week and 26-week follow-up relative to controls who received usual care.” (BMJ Open, 2013) [2] The durability of those effects across 26 weeks is particularly notable, showing that humor therapy produces benefits that persist well beyond the active intervention period.

University of Sydney researcher Lee-Fay Low found equally striking results in earlier work. “New research indicates that laughter may be just as effective as antipsychotic medications for reducing anxiety in elderly people with dementia,” Low reported in 2008, adding that “the laughter resulted in a 20 percent plunge in overall agitation.” (AgingCare, 2008) [5] Comparing humor interventions favorably with antipsychotic medications – drugs that carry black-box FDA warnings for use in elderly dementia patients – is a finding with significant implications for clinical practice and opioid-alternative care models.

A 2006 pilot study published in PubMed concluded that humor therapy serves as an additional therapeutic tool for patients with late-life depression or Alzheimer’s disease, reinforcing the dual relevance of laughter-based care for the overlapping symptoms of cognitive decline and mood disorders (PubMed, 2006). [6]

How Does Laughter Therapy Work in the Brain?

Laughter therapy produces measurable physiological and neurological changes that directly address the biological mechanisms driving dementia-related distress. Understanding these pathways explains why humor is not merely a pleasant distraction but a clinically active intervention with quantifiable effects on brain chemistry, immune function, and stress response.

When a person laughs – whether spontaneously in response to comedy or through deliberate laughter exercises – the brain releases endorphins, the body’s natural pain-relieving and mood-elevating neurotransmitters. Simultaneously, levels of cortisol, the primary stress hormone, fall. In dementia patients, chronic elevated cortisol is associated with accelerated cognitive decline, increased agitation, and disrupted sleep patterns. Laughter’s cortisol-lowering effect therefore addresses a key physiological driver of behavioral symptoms.

Laughter therapy also stimulates the immune system by increasing the production of immunoglobulins and activating natural killer cells – a benefit that is particularly relevant for older adults with dementia, whose immune function is compromised. The cardiovascular benefits of laughter therapy are well documented: a 2019 study published in PMC found that a four-week laughter therapy program in older adults produced significant reductions in both systolic blood pressure and heart rate (PMC, 2019). [3]

T. Koizumi et al. summarized the combined physiological effects clearly: “The intervention of laughter therapy once a week for 4 weeks resulted in a significant reduction in blood pressure and heart rate, alleviation of geriatric depression and bodily pain, and improvement of sociability and activity.” (PMC, 2019) [3] For dementia patients, improvements in sociability and activity are especially meaningful, as social withdrawal and physical passivity are hallmark behavioral symptoms that reduce quality of life and accelerate functional decline.

A systematic review and meta-analysis published in 2019 offered an important nuance for clinical application, finding that “‘Simulated’ (non-humorous) laughter is more effective than ‘spontaneous’ (humorous) laughter, and laughter-inducing therapies can improve depression.” (White Rose Research, 2019) [7] This finding matters for dementia care because patients with advanced cognitive impairment do not reliably process verbal humor or follow comedic narratives – but guided laughter exercises that do not depend on comprehension still deliver the physiological benefits of laughter. Practitioners working with mid-to-late stage dementia populations should design their interventions with this distinction in mind, prioritizing exercise-based laughter techniques over content-dependent approaches.

The social dimension of laughter also carries neurological weight. Group laughter activates mirror neurons and promotes feelings of belonging and safety – emotional states that reduce agitation and anxiety in dementia patients who experience significant distress from disorientation and environmental uncertainty. Connecting through shared laughter is one of the few communication channels that remains accessible even when verbal language capacity diminishes significantly.

How Is Laughter Therapy Delivered in Clinical Settings?

Laughter therapy in dementia care settings is delivered through several structured models, each suited to different levels of patient cognitive function, facility resources, and staff capacity. Effective implementation draws on trained personnel, curated content, and consistent scheduling rather than ad hoc moments of humor during routine care.

The ElderClown model – formalized in the SMILE study – uses professional therapeutic clowns who visit nursing home residents on a regular schedule. These trained performers adapt their routines to individual residents, using physical comedy, music, and gentle improvisation that does not rely on verbal comprehension. The research on laughter benefits for older adults from UCLA Health reinforces the case for consistent, structured delivery over occasional informal humor. ElderClown programs show benefits even in late-stage dementia patients who respond minimally to conventional therapeutic activities.

The LaughterBoss model trains existing care staff – nurses, aides, activity coordinators – to incorporate humor intentionally into daily care interactions. This approach is more scalable and cost-effective than bringing in external performers, and the SMILE study demonstrated that trained staff delivering humor interventions achieve statistically significant reductions in agitation without specialist intervention. Staff training covers humor techniques suited to cognitively impaired patients, recognizing individual humor preferences, and avoiding humor that confuses or distresses vulnerable residents.

A third delivery model relies on curated comedy media – short comedy clips, classic television programs, or comedy audio content played during group sessions or individual care time. The LaughMD personalized digital wellness platform, operated by our sister entity LaughMD (laughmd.com), uses this approach, curating comedy tailored to individual patient preferences to maximize engagement and therapeutic response. Digital delivery is particularly valuable in home care and outpatient settings where live performer access is not feasible.

Group laughter therapy sessions – sometimes structured as laughter yoga circles – combine intentional breathing, movement, and laughter exercises in a group format. These sessions do not require cognitive engagement with humor content, making them accessible to patients across the dementia severity spectrum. Facilitating a weekly group session of 20 to 30 minutes shows measurable improvements in mood and social engagement in elder care research. For facilities introducing laughter-based interventions, a peer-reviewed academic foundation for humor in healthcare supports evidence-based program design and clinician buy-in.

Your Most Common Questions

Does laughter therapy actually reduce agitation in dementia patients?

Laughter therapy for dementia significantly reduces agitation, with effects lasting up to 26 weeks after the intervention ends, as confirmed by multiple peer-reviewed clinical trials. The SMILE study, a cluster randomized trial published in BMJ Open in 2013, found that humor therapy produced a statistically significant reduction in agitation scores compared with usual care (p = 0.045), with adjusted mean differences corresponding to two agitated behaviors dropping in frequency from daily to approximately once per week (BMJ Open, 2013). [2] University of Sydney researcher Lee-Fay Low reported a 20 percent reduction in overall agitation in dementia patients who received humor-based interventions, noting that laughter is as effective as antipsychotic medications for reducing anxiety in this population (AgingCare, 2008). [5] The persistence of these benefits – confirmed at both 13-week and 26-week follow-up in the SMILE trial – distinguishes laughter therapy from many pharmaceutical approaches that require continuous dosing to maintain effect. For care teams managing the behavioral and psychological symptoms of dementia, these findings support humor-based intervention as a meaningful, evidence-grounded component of a broader care plan.

What types of laughter therapy work best for people with advanced dementia?

Simulated laughter techniques – exercises that produce laughter without relying on humor comprehension – work best for people with moderate to advanced dementia. A 2019 systematic review and meta-analysis found that simulated laughter is more effective than spontaneous humor-triggered laughter for improving depression, and laughter-inducing therapies broadly reduce depressive symptoms in older populations (White Rose Research, 2019). [7] This distinction matters clinically because patients with advanced dementia are unable to follow a comedic narrative, understand a punchline, or engage with verbal humor. Physical and movement-based laughter exercises – including laughter yoga techniques – bypass the need for cognitive humor processing entirely, delivering the physiological benefits of laughter (endorphin release, cortisol reduction, blood pressure lowering) through the act of laughing itself. ElderClown programs that use physical comedy, music, and sensory engagement have also demonstrated effectiveness with late-stage dementia residents. For facilities developing humor therapy programs, layering simulated laughter exercises for group sessions with individualized comedy media for higher-functioning residents creates a tiered approach that serves patients across the cognitive impairment spectrum.

How does laughter therapy for dementia compare with antipsychotic medication?

Laughter therapy for dementia shows comparable effectiveness to antipsychotic medications for reducing anxiety and agitation, with none of the associated side effects or safety risks. University of Sydney researcher Lee-Fay Low stated in 2008 that “new research indicates that laughter may be just as effective as antipsychotic medications for reducing anxiety in elderly people with dementia” – a comparison that carries significant weight given that antipsychotics carry FDA black-box warnings for increased mortality risk in elderly dementia patients (AgingCare, 2008). [5] Antipsychotic medications used to manage behavioral symptoms of dementia – including risperidone and haloperidol – are associated with sedation, extrapyramidal effects, increased stroke risk, and higher all-cause mortality. Laughter therapy carries none of these risks and is delivered safely by trained care staff or through comedy media without medical oversight. The Mayo Clinic also recognizes laughter as a legitimate tool for stress relief, noting its physiological benefits for the cardiovascular and immune systems. For clinical teams and families weighing behavioral management options, laughter therapy offers a compelling first-line or adjunct intervention before escalating to pharmacological approaches.

Can caregivers use laughter therapy at home for a family member with dementia?

Caregivers effectively introduce laughter therapy for dementia at home using comedy media, simple laughter exercises, and humor-based interaction techniques without formal clinical training. The evidence base for humor interventions does not require a clinical setting: the physiological mechanisms – endorphin release, cortisol reduction, blood pressure lowering – activate regardless of whether laughter occurs in a nursing home, a hospital, or a family living room. Home-based approaches that have demonstrated value include playing short comedy video clips matched to the patient’s sense of humor, introducing gentle laughter yoga breathing and vocalization exercises, and cultivating playful, lighthearted interaction during daily care routines. A 2019 study in PMC found that four weeks of once-weekly laughter therapy produced significant improvements in blood pressure, heart rate, depression scores, and pain levels in older adults – a protocol easily adapted for home use (PMC, 2019). [3] Caregivers implementing laughter-based approaches at home benefit from practical guidance on selecting appropriate humor content, pacing sessions to avoid fatigue, and recognizing when a family member is responding positively. The LaughMD book provides a step-by-step prescription for caregivers, covering content selection, session structure, and how to tailor humor to individual preferences and cognitive capacity.

Comparing Laughter Therapy Approaches for Dementia Care

Laughter therapy for dementia is not a single method – it encompasses several distinct delivery models, each with different resource requirements, clinical evidence, and applicability across dementia severity levels. The table below compares the four primary approaches to help care teams and caregivers select the most appropriate intervention for their setting.

ApproachHow It’s DeliveredEvidence StrengthBest ForResource Level
ElderClown ProgramsProfessional therapeutic clowns visiting care facilitiesStrong – SMILE trial (BMJ Open, 2013) [2]Moderate to late-stage dementia in residential careHigh – requires trained external performers
LaughterBoss (Staff-Led)Trained care staff incorporating humor into daily interactionsStrong – SMILE trial (BMJ Open, 2013) [2]All dementia stages in nursing home settingsMedium – requires staff training program
Simulated Laughter ExercisesGuided group laughter and breathing sessions (laughter yoga)Moderate – 2019 meta-analysis supports depression improvement [7]Advanced dementia; patients who cannot process verbal humorLow – minimal training, no specialist required
Comedy Media (Curated)Comedy video or audio content matched to patient preferencesModerate – supported by physiological studies (PMC, 2019) [3]Mild to moderate dementia; home care; outpatient settingsLow – accessible via smartphone, TV, or digital platform

How LaughMD Supports Humor-Based Dementia Care

At LaughMD, we translate the growing body of clinical research on laughter therapy for dementia into practical, accessible resources for healthcare providers, patients, and caregivers. Our work is grounded in over 400 peer-reviewed studies and validated by real clinical outcomes – not anecdote or conjecture.

Our flagship resource, If Laughter is the Best Medicine – Let’s Use It as Medicine: The New Science of Humor in Healthcare by Prof. Frank Chindamo, CHP, brings together the mechanisms, clinical evidence, and practical application of humor-based interventions in a format designed for both clinical professionals and family caregivers. The book covers the neuroscience of laughter, real-world examples from oncology and elder care settings, and a dedicated practical “How To” section with step-by-step guidance for patients, clinicians, and caregivers implementing humor interventions. You can explore and purchase the ebook, audiobook, and print editions through the LaughMD Shop – purchase the ebook, audiobook, deluxe audiobook, and print editions of “If Laughter is the Best Medicine.”

“Prof. Chindamo’s work provides a comprehensive and funny exploration of why humor belongs in the healing process. It’s an essential resource for practitioners and patients alike.” – Gina Ramsey, LICSW – Author, Writer, Speaker, Life Transformation Strategist at Minneapolis VA Healthcare System

“A compelling presentation of science and clinical application. This hilarious book proves how laughter can be a legitimate, data-backed medical intervention.” – Joseph B. Singer, MD – Senior Attending Physician at East Bay Community Action Program, Providence, RI

For healthcare administrators, clinical educators, and researchers looking to integrate humor-based care into institutional protocols, we offer bulk orders and institutional licensing arrangements. Our team – including clinical social workers with Stanford affiliation, comedians, and comedy writers – ensures that every resource we produce delivers both genuine entertainment value and clinical credibility. Learn more about the team and the research foundation behind LaughMD at the About LaughMD page – Prof. Frank Chindamo’s background, the LaughMD framework, and the clinical research foundation.

For bulk purchases, media inquiries, or questions about incorporating the LaughMD framework into your facility’s dementia care program, Contact LaughMD – for bulk orders, institutional licensing, media inquiries, and general questions or email us directly at [email protected].

How to Introduce Laughter Therapy for Dementia in 5 Steps

Step 1: Assess the Individual’s Humor Profile and Cognitive Level

Before introducing any laughter therapy program, identify what types of humor the person with dementia responds to – physical comedy, music, familiar television programs, or gentle wordplay – and assess their current cognitive stage. This assessment determines which delivery model (curated media, simulated laughter exercises, or ElderClown-style interaction) is most appropriate and ensures the intervention is personalized rather than generic.

Step 2: Select the Right Delivery Format for Your Setting

Match the delivery format to your available resources: comedy media and laughter yoga exercises require minimal equipment and no specialist training, making them ideal for home caregivers and under-resourced care facilities. Facilities with capacity can invest in staff LaughterBoss training or periodic ElderClown visits for higher-intensity programming. The SMILE study demonstrated that both trained staff and professional clown models produce significant, lasting reductions in dementia-related agitation (BMJ Open, 2013). [2]

Step 3: Schedule Consistent, Regular Sessions

The evidence supports structured, recurring sessions rather than opportunistic humor moments – T. Koizumi et al. found that laughter therapy delivered once weekly for four weeks produced significant improvements in blood pressure, heart rate, depression, and sociability (PMC, 2019). [3] Schedule sessions at a time of day when the patient is most alert and settled, typically mid-morning, and keep each session to 20 to 30 minutes to prevent fatigue.

Step 4: Monitor and Document Behavioral and Emotional Outcomes

Track agitation frequency, mood, and engagement levels before and after each session using validated tools such as the Cohen-Mansfield Agitation Inventory or the Geriatric Depression Scale – the same measures used in the clinical trials that generated the evidence base for laughter therapy. Documentation creates an objective record of progress, supports clinical communication, and builds the case for ongoing institutional investment in humor-based care programs.

Step 5: Integrate Laughter Therapy Into the Broader Care Plan

Position laughter therapy for dementia as a complement to existing behavioral, pharmacological, and occupational therapy approaches – not a replacement for any element of standard care. Communicate outcomes to the full care team, include humor-based goals in care planning documentation, and revisit the humor profile regularly as cognitive status changes. Patients in mid-to-late dementia stages require a shift from content-based comedy to simulated laughter exercises as their capacity to process humor narratives declines.

The Bottom Line

Laughter therapy for dementia is one of the most evidence-supported, side-effect-free interventions available for managing the behavioral and psychological symptoms of cognitive decline. Peer-reviewed trials from the SMILE study and multiple university research programs have confirmed that structured humor interventions reduce agitation, lower depression scores, and increase observable happiness in nursing home and elder care settings – with benefits lasting up to 26 weeks. The Mayo Clinic’s recognition of laughter as a legitimate stress management tool reflects the growing mainstream clinical acceptance of humor as medicine.

Whether you’re a clinician exploring non-pharmacological behavioral management strategies, a hospital administrator building a dementia care program, or a caregiver supporting a family member at home, the science gives you a clear foundation to act on. LaughMD makes that foundation accessible in formats built for every setting. Explore our resources at the LaughMD Shop, or reach out to us at [email protected] to discuss bulk orders, institutional licensing, or media inquiries. Laughter is the prescription – and the evidence is in.


Sources & Citations

  1. Humor therapy and agitation/happiness outcomes in nursing home residents. PubMed, 2014.
    https://pubmed.ncbi.nlm.nih.gov/24814320/
  2. The Sydney Multisite Intervention of LaughterBosses and ElderClowns (SMILE) study. BMJ Open, 2013.
    https://bmjopen.bmj.com/content/3/1/e002072
  3. Beneficial effect of laughter therapy on physiological and psychological function in elderly patients. PMC, 2019.
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6279721/
  4. Laughter and humor in dementia – review of complementary and alternative intervention evidence. PMC, 2010.
    https://pmc.ncbi.nlm.nih.gov/articles/PMC2896339/
  5. Laughter May Be as Effective as Meds in Dementia Treatment. AgingCare, 2008.
    https://www.agingcare.com/articles/laughter-effective-dementia-treatment-148090.htm
  6. Humor therapy as an additional therapeutic tool for late-life depression or Alzheimer’s disease. PubMed, 2006.
    https://pubmed.ncbi.nlm.nih.gov/16977676/
  7. Laughter-inducing therapies: systematic review and meta-analysis. White Rose Research, 2019.
    https://eprints.whiterose.ac.uk/id/eprint/143061/16/1-s2.0-S0277953619300851-main.pdf

Similar Posts

Leave a Reply